Back
Speaker illustration

Doctor Loubna Dari

University Hospital of Bordeaux, Bordeaux (France)

Member of:

European Society of Cardiology

Presentations

Effectiveness and safety of rivaroxaban vs apixaban in patients with Atrial Fibrillation and Peripheral Artery Disease

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Adjuvant strategies to peripheral artery disease

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources